Inhaled Drug Product Development
Developing an inhaled drug product?
Integrated capabilities and expertise for nasal and pulmonary delivery
Quotient Sciences has a proven track record in the development and manufacturing of inhaled drug products over the last four decades. We have experience across a range of drug delivery platforms including dry powder inhalers (DPIs) and solutions/suspensions for inhalation.
With integrated capabilities and vast knowledge of nasal and pulmonary delivery, we help our clients accelerate their molecules from first-in-human, through to proof-of-concept and into full development.
Our extensive expertise and capabilities for nasal and pulmonary delivery include:
- Pre-formulation and API characterisation
- Formulation and process development
- Inhaled device evaluation and selection
- Clinical manufacturing and supply (Phase I-III)
- Clinical pharmacology assessments
We have a wide range of processing and analytical equipment to support the development and manufacture of inhaled drug products:
- Spray drying
- Micronization
- Blending and encapsulation
- Aerosol characterization
Learn more about our inhaled drug product development
-
Info SheetInhaled Product DevelopmentWith more than 30 years’ experience, Quotient is a leader in the development, manufacture and assessment of inhalation products, helping clients to accelerate molecules from first-in-human through to proof-of-concept.
-
Case StudiesPulmatrixBreathing new life into Phase 1 trials. Quotient's approach is helping Pulmatrix to develop a range of inhaled dry powder chemical entities based on its iSPERSE™ technology to meet unmet medical needs in multiple respiratory diseases.
-
WebinarStrategies for Achieving Regulatory Milestones FasterWatch our on-demand webinar featuring a customer case study from Ensysce Biosciences' CEO Lynn Kirkpatrick on choosing an integrated service provider to accelerate drug development.
-
WebinarQuotient Sciences and Charles River Collaboration WebinarWatch Quotient Sciences & Charles River webinar on-demand entitled, 'Integrated Strategies for Accelerating from Discovery to IND and Beyond: Charles River & Quotient Sciences Collaboration'.
Ready to get started?
Connect with our experts
Share Your Development Challenge with our Scientists
Let's Talk